Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2022 Jun 27

PMID 35757195

Authors

Amanda Wojtusik Orabone

Vincent Do

Elizabeth Cohen

Affiliations

Soon will be listed here.

Abstract

The health and economic burden of diabetes mellitus across the United States and the world is such that effective care is crucial to improving outcomes, including macro and microvascular complications, and lowering health care costs. Pharmacists are well placed within communities to provide the critical care necessary for patients with diabetes and have a unique skillset that has demonstrated clear benefits in clinical and non-clinical outcomes. Here, we will provide a narrative review of the literature including the role of the pharmacist in different care models, outcomes associated with pharmacist care, and future directions and opportunities for pharmacist-managed diabetes.

Citing Articles

Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services.

Kweyete O, Woods D, Okoumba J, Guo S, Allen J J Am Coll Clin Pharm. 2025; 8(1):47-51.

PMID: 40051646 PMC: 11880900. DOI: 10.1002/jac5.2050.

Pharmacist-Led Digital Health Interventions for Patients with Diabetes: A Systematic Review.

Christy A, Fernanda F, Insani W, Abdulah R J Multidiscip Healthc. 2025; 18():101-112.

PMID: 39822966 PMC: 11735830. DOI: 10.2147/JMDH.S494584.

Diabetes Management: A Case Study to Drive National Policy Change in Primary Care Settings.

Bannuru R, Prieto F, Murdock L, Tollefson E Ann Fam Med. 2024; 22(6):550-556.

PMID: 39586698 PMC: 11588362. DOI: 10.1370/afm.3175.

Overcoming therapeutic inertia in newly diagnosed type 2 diabetes: Protocol of a randomized, quality improvement trial.

Thai T, Board C, Nugent J, Johnston J, Huynh E, Chen C Contemp Clin Trials. 2024; 148:107751.

PMID: 39557156 PMC: 11896600. DOI: 10.1016/j.cct.2024.107751.

Novel Pharmacy Model: Pharmacy Diabetes Clinic in Abdominal Transplant Recipients.

Sweiss H, Hall R, Bhayana S, Patel R, Flores M, Long C Diabetes Spectr. 2024; 37(2):170-174.

PMID: 38756424 PMC: 11093761. DOI: 10.2337/ds23-0025.

References

Fazel M, Bagalagel A, Lee J, Martin J, Slack M . Impact of Diabetes Care by Pharmacists as Part of Health Care Team in Ambulatory Settings: A Systematic Review and Meta-analysis. Ann Pharmacother. 2017; 51(10):890-907. DOI: 10.1177/1060028017711454. View

Do V, Haakinson D, Belfort-DeAguiar R, Cohen E . Implementing a pharmacist-led transition of care model for posttransplant hyperglycemia. Am J Health Syst Pharm. 2021; 78(13):1207-1215. PMC: 8083386. DOI: 10.1093/ajhp/zxab151. View

Odegard P, Carpinito G, Christensen D . Medication adherence program: adherence challenges and interventions in type 2 diabetes. J Am Pharm Assoc (2003). 2013; 53(3):267-72. DOI: 10.1331/JAPhA.2013.12065. View

Lin C, Tran N, Muradian I, Do N, Lu Q, Tesema L . Impact of a Pharmacist-Led Diabetes Clinic in a Correctional Setting. J Pharm Pract. 2019; 34(4):596-599. DOI: 10.1177/0897190019888075. View

Fantasia K, Stockman M, Ju Z, Ortega P, Crable E, Drainoni M . Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: Results of a clinical pilot program. J Clin Transl Endocrinol. 2021; 24:100254. PMC: 8054187. DOI: 10.1016/j.jcte.2021.100254. View

Chung N, Rascati K, Lopez D, Jokerst J, Garza A . Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population. J Manag Care Spec Pharm. 2014; 20(9):914-9. PMC: 10437343. DOI: 10.18553/jmcp.2014.20.9.914. View

Murphy J, Schroeder M, Ridner A, Gregory M, Whitner J, Hackett S . Impact of a Pharmacy-Initiated Inpatient Diabetes Patient Education Program on 30-Day Readmission Rates. J Pharm Pract. 2019; 33(6):754-759. DOI: 10.1177/0897190019833217. View

Sullivan J, Jett B, Cradick M, Zuber J . Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting. Ann Pharmacother. 2016; 50(12):1023-1027. DOI: 10.1177/1060028016663564. View

Hawes E, Lambert E, Reid A, Tong G, Gwynne M . Implementation and evaluation of a pharmacist-led electronic visit program for diabetes and anticoagulation care in a patient-centered medical home. Am J Health Syst Pharm. 2018; 75(12):901-910. DOI: 10.2146/ajhp170174. View

10.

Wubben D, Vivian E . Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008; 28(4):421-36. DOI: 10.1592/phco.28.4.421. View

11.

Rochester C, Leon N, Dombrowski R, Haines S . Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2010; 67(1):42-8. DOI: 10.2146/ajhp080706. View

12.

Batta R, Kasabri V, Akour A, Hyassat D, Albsoul-Younes A . Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan. Int J Clin Pharm. 2017; 40(1):48-55. DOI: 10.1007/s11096-017-0550-3. View

13.

Shi F, Shen L, Pan M, Ma L, Zhang C, Gu Z . The Successful Rapid Adjustment of Blood Glucose in a Patient With Acute Coronary Syndrome, Renal Insufficiency, and Diabetes: A Case Report of Management Coordinated by Clinical Pharmacists and Clinicians. Front Pharmacol. 2020; 11:756. PMC: 7253704. DOI: 10.3389/fphar.2020.00756. View

14.

Norton M, Haftman M, Buzzard L . Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use. J Am Board Fam Med. 2020; 33(5):745-753. DOI: 10.3122/jabfm.2020.05.200044. View

15.

Farland M, Byrd D, McFarland M, Thomas J, Franks A, George C . Pharmacist-physician collaboration for diabetes care: the diabetes initiative program. Ann Pharmacother. 2013; 47(6):781-9. DOI: 10.1345/aph.1S079. View

16.

Pousinho S, Morgado M, Placido A, Roque F, Falcao A, Alves G . Clinical pharmacists´ interventions in the management of type 2 diabetes mellitus: a systematic review. Pharm Pract (Granada). 2020; 18(3):2000. PMC: 7470242. DOI: 10.18549/PharmPract.2020.3.2000. View

17.

Lewis J, Nguyen T, Althobaiti H, Alsheikh M, Borsari B, Cooper S . Impact of an Advanced Practice Pharmacist Type 2 Diabetes Management Program: A Pilot Study. Innov Pharm. 2021; 10(4). PMC: 8051896. DOI: 10.24926/iip.v10i4.2237. View

18.

Collier I, Baker D . Implementation of a pharmacist-supervised outpatient diabetes treatment clinic. Am J Health Syst Pharm. 2013; 71(1):27-36. DOI: 10.2146/ajhp130200. View

19.

Benedict A, Spence M, Sie J, Chin H, Ngo C, Salmingo J . Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System. J Manag Care Spec Pharm. 2018; 24(2):114-122. PMC: 10398151. DOI: 10.18553/jmcp.2018.24.2.114. View

20.

Maxwell L, McFarland M, Baker J, Cassidy R . Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population. Pharmacotherapy. 2016; 36(3):348-56. DOI: 10.1002/phar.1719. View